BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Resistance to TKIs in CML is associated with different phenomena, including mutations in the fusion protein BCR-ABL and several chromatin-related processes in which H1 may be involved, such as DNA repair, genome instability, and epigenetic dysfunction [36,38,39,40,41].